Computational Biology companies

Centrillion Technologies develops high-density DNA chips and wafer-scale manufacturing systems for biomolecular analysis in genomics and spatial biology.

Absentia Labs builds AI foundation models for medicine, focusing on predicting drug safety and efficacy to accelerate drug development, with its Digital Liver M…

Protein Metrics provides vendor-neutral mass spectrometry data analysis software for protein characterization, quantification, and proteomics research, serving…

The Chan Zuckerberg Biohub is a collaborative research organization combining AI, machine learning, and biology to develop tools and models aimed at advancing b…

Tahoe Therapeutics develops a platform generating gigascale single-cell maps of drug-cell interactions for drug discovery, along with large-scale biological dat…

San Francisco AI-native drug discovery company building generative models of intrinsically disordered proteins for neurodegeneration and cancer targets.

Achira builds atomistic foundation simulation models combining deep learning and quantum chemistry to advance drug discovery.

Merge Labs is a neurotechnology research lab developing brain-computer interfaces using molecules and ultrasound, aiming to bridge biological and artificial int…

Just – Evotec Biologics develops and operates a continuous biologics manufacturing platform to reduce the cost of antibody therapies and biosimilars for partner…

Chai Discovery builds AI models to predict and redesign biochemical molecular interactions, accelerating drug discovery for antibody design, GPCR agonists, and…

Azenta Life Sciences provides automated biological sample storage, cold-chain logistics, laboratory informatics, and genomic sequencing services to pharma, biot…

Pathos is a clinical-stage biotech developing an AI-driven platform that integrates biological modelling and large-scale oncology patient data to improve precis…

Global biotechnology company providing drug discovery, preclinical development and biologics manufacturing services to pharmaceutical partners.